The company has received final approval from the United States Food and Drug Administration (USFDA) for its Nevirapine tablets in the strength of 200 mg and Nevirapine oral suspension in the strength of 50 mg/5ml, Aurobindo Pharma said in a statement
According to IMS health data the products have a market size of approximately $125 million for the twelve months ending December 2011
http://www.business-standard.com/india/news/aurobindo-pharma-gets-us-nod-for-generic-anti-hiv-drug/165700/on
No comments:
Post a Comment